Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00704353 · ClinicalTrials.gov registry record · Phase 3
Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia
A Phase 3 study, sponsored by American Regent.
- Completed
- Registry status
- Phase 3
- Development phase
- 735
- Enrollment target
NCT00704353 is a Phase 3 study that has completed, run by American Regent. The registered enrollment target is 735 participants.
The verdict
NCT00704353, a Phase 3 study, has completed, sponsored by American Regent.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 735 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety of FCM in patients with anemia who are not dialysis dependent
Interventions
- DRUG Ferric Carboxymaltose
- DRUG Standard Medical Care (SMC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 735 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00704353
The ClinicalTrials.gov registry entry for NCT00704353 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 735 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Regent, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ferric Carboxymaltose is the first listed.
NCT00704353 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00704353 about?
NCT00704353 is a clinical study titled "Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia". The objective of this study is to evaluate the safety of FCM in patients with anemia who are not dialysis dependent
What is the current status of trial NCT00704353?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 735 participants. The study started on 2008-06. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00704353?
The interventions under investigation include: Ferric Carboxymaltose (DRUG), Standard Medical Care (SMC) (DRUG).
Who is sponsoring clinical trial NCT00704353?
This trial is sponsored by American Regent, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.